Argentil injects capital into Nigerian pharmaceutical company

 Argentil injects capital into Nigerian pharmaceutical company
Àrgentil Capital Management, a boutique financial services firm, has announced an equity investment in Nigeria’s Sygen Pharmaceuticals Ltd along with co-investors. The quantum of the deal, which included co-investors such as Consumer Growth Partners, was not disclosed. But Àrgentil said the investment will help Sygen meet demand for affordable drugs […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest